Analystreport

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) had its price target raised by analysts at SVB Leerink LLC from $8.00 to $10.00. They now have an "outperform" rating on t

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com